Gilead Sciences, Inc. (GILD) Misses Q4 EPS by 8c, Sales Top Slightly
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $67.03 +0.12%
EPS Growth %: +13.9%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: +13.9%
Financial Fact:
Income from operations: 4.4B
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.97, $0.08 worse than the analyst estimate of $1.05. Revenue for the quarter came in at $2.2 billion versus the consensus estimate of $2.18 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Steel Dynamics (STLD) Tops Q1 EPS by 16c
- Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
